Journal of Biological Chemistry · 1974 · 147 citations · 8 references
Life SciencesBiochemistryPharmacologyCell SignalingMolecular PharmacologySignal TransductionAdrenal HormonesHormone ReceptorsLigand BindingReceptor PharmacologyReceptor PhysiologyReceptor RegulationAdrenal Cortex PhysiologyAngiotensin Receptor SignalingAssayEnzyme Conformational Change
AngiotensinII binding to adrenal cortex receptors is inhibited with high specificity by GTP, 5'-guanilylimidophosphate, (Gpp(NH)p), and ITP.Half-maximum inhibition of angiotensin II binding is achieved with 1.6 X 1O-7 M GTP in the presence of a nucleotide-regenerating system, and Gpp-(NH)p is equally effective in the absence of the nucleotideregenerating system.Guanosine 3': 5'-monophosphate, 5'-GMP, ATP, and UTP demonstrate little or no inhibition at concentrations which were l,OOO-to lO,OOO-fold higher than those of Gpp(NH)p or GTP.Inclusion of the guanyl nucleotides (GTP and Gpp(NH)p) in the binding assay leads to a lower steady state binding of the hormone to its receptor, and addition of these nucleotides to the binding assay at steady state leads to a rapid release of bound tracer angiotensin II.It is proposed that these actions of the guanyl nucleotides are based on a conformational change at the receptor level.
8